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Abstract
Cyclic nucleotide signalling is a major regulator of malaria parasite differentiation. Phospho-
diesterase (PDE) enzymes are known to control cyclic GMP (cGMP) levels in the parasite,
but the mechanisms by which cyclic AMP (cAMP) is regulated remain enigmatic. Here, we
demonstrate that Plasmodium falciparum phosphodiesterase β (PDEβ) hydrolyses both
cAMP and cGMP and is essential for blood stage viability. Conditional gene disruption
causes a profound reduction in invasion of erythrocytes and rapid death of those merozoites
that invade. We show that this dual phenotype results from elevated cAMP levels and hyper-
activation of the cAMP-dependent protein kinase (PKA). Phosphoproteomic analysis of
PDEβ-null parasites reveals a >2-fold increase in phosphorylation at over 200 phosphosites,
more than half of which conform to a PKA substrate consensus sequence. We conclude
that PDEβ plays a critical role in governing correct temporal activation of PKA required for
erythrocyte invasion, whilst suppressing untimely PKA activation during early intra-erythro-
cytic development.
Author summary
Cyclic nucleotide signalling pathways are ubiquitous in eukaryotes and regulate a plethora
of cellular processes. Pathway components include cyclases and phosphodiesterases that
synthesise and break down the intracellular second messengers cyclic AMP (cAMP) and
cyclic GMP (cGMP); the signal is translated into a cellular response by effector kinases
activated by elevated cyclic nucleotide levels. Malaria parasites deploy cyclic nucleotide
signalling to regulate virtually every stage of their complex life cycle. Using a conditional
gene knockout approach, we investigate the function of phosphodiesterase β (PDEβ) in
the disease-causing blood stage parasites. PDEβ disruption causes a severe reduction in
erythrocyte invasion and rapid post-invasion death. Although we show that PDEβ can
hydrolyse cAMP and cGMP, both parts of the phenotype are linked to elevated cAMP lev-
els and hyperactivation of PKA. Quantitative phosphoproteomic analysis identified sites
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that are differentially phosphorylated in the PDEβ knockout, revealing a role for cAMP
signalling in cellular processes ranging from chromatin organisation to protein synthesis,
as well as the regulation of parasite-specific components of the erythrocyte invasion
machinery. In summary, PDEβ disruption causes a profound dysregulation of key events
during blood stage replication that could be exploited for the development of new antima-
larial drugs.
Introduction
The malaria parasite life cycle comprises extended phases in both a human host and a mos-
quito vector, but little is known of the control mechanisms that orchestrate progression of par-
asite development and transmission. Asexually replicating blood stage forms cause all the
symptoms and pathology associated with malaria, whereas sexual stage parasites called game-
tocytes are required to mediate transmission to mosquitoes. Cyclic nucleotide signalling is
important at most of the key stages of the parasite life cycle in both the host and vector. A role
for cyclic GMP (cGMP)–dependent protein kinase (PKG) has been demonstrated in blood
stage egress [1, 2] and invasion [3], gametogenesis [4], ookinete motility [5, 6], and sporozoite
motility required for invasion of mosquito vector salivary glands and host hepatocytes [7–9].
Available evidence suggests a role for cyclic AMP (cAMP)–dependent protein kinase (PKA) in
blood stage invasion [10–12], cell cycle progression [13, 14], anion conductance, and gameto-
cyte deformability [15, 16] as well as regulated exocytosis of sporozoite apical organelles and
hepatocyte infectivity [17]. Two recent studies on cAMP signalling in Toxoplasma gondii have
shown that absence of one of the three PKA catalytic subunits (PKAc1) leads to premature
egress of tachyzoites [18, 19]. These studies also revealed roles for PKAc1 in cross talk with
cGMP signalling at this stage of the life cycle. An earlier study established a role for PKAc3
in negative regulation of bradyzoite differentiation [20]. Additional key players in cyclic
nucleotide signalling are purine nucleotide cyclases, which synthesise cAMP and cGMP from
adenosine triphosphate (ATP) and guanosine triphosphate (GTP), respectively, and cyclic
nucleotide phosphodiesterases (PDEs), which break down these messenger molecules by
hydrolysis. Cyclic nucleotide levels in the cell are balanced by the opposing action of these two
enzyme classes and, upon reaching a concentration threshold, activate their respective cyclic
nucleotide-dependent protein kinases, PKA and PKG.
The P. falciparum genome encodes four PDEs (PlasmoDB identifiers: PDEα,
PF3D7_1209500; PDEβ, PF3D7_1321500; PDEγ, PF3D7_1321600; and PDEδ,
PF3D7_1470500). Reverse genetic approaches have demonstrated that PDEα, PDEγ, and
PDEδ are all associated with cGMP hydrolysis but are not essential for blood stage replication
[6, 9, 21–23]. In contrast, previous attempts to delete PDEβ in P. falciparum were unsuccessful,
suggesting that the enzyme might be essential for asexual blood stage development. Consistent
with this, the P. berghei PlasmoGEM global gene knockout project and a recent P. falciparum
global transposon mutagenesis project defined P. berghei PDEβ (PbPDEβ,PBANKA_141980)
and P. falciparum PDEβ (PfPDEβ) as likely essential based on an extremely low relative growth
rate of gene knockout parasites (http://plasmogem.sanger.ac.uk/) [24] and the absence of
transposon insertion [25], respectively. Collectively, these data suggest that PDEβ is the only
essential PDE in the clinically relevant asexual blood stages of the parasite life cycle. Attempts
to express recombinant PDEβ have also been unsuccessful. As a result, its substrate specificity
and molecular function in the parasite are unknown.
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Here, we have used a conditional genetic approach to investigate the essentiality and role of
PDEβ in P. falciparum blood stage development. This has revealed a critical role in blood stage
growth that is likely the result of dysregulated PKA activity.
Results and discussion
PfPDEβ is a dual-specific PDE that translocates from a likely apical
location to a peripheral membrane of merozoites
PfPDEβ is expressed during asexual blood stage development with mRNA levels increasing in
the second half of the approximately 48-hour cycle and peaking in mature schizonts (http://
plasmodb.org/). The presence of six putative transmembrane domains distinguishes PfPDEβ
from all but one (hPDE3) of the 11 human PDE families that are otherwise soluble [26]. It is
currently not possible to predict the substrate specificity of a PDE from its sequence, as this is
thought to be defined by multiple components of the binding pocket [27], but sequence com-
parisons of the catalytic domain of PfPDEβ with selected mammalian PDEs show that 14 of
the 15 residues that are invariant amongst all human PDEs are conserved in PfPDEβ (S1 Fig).
This suggests that it is a bona fide enzymatically active PDE.
Using a transgenic P. falciparum line in which PfPDEβ was tagged with a triple haemagglu-
tinin (3×HA) tag (PfPDEβHA, S2A and S2B Fig), expression was detectable by immunofluores-
cence (IFA) throughout blood stage development (S2C Fig). In a western blot time course, a
band at around the expected size of the tagged protein (about 136 kDa) was most intense at the
late schizont stage (Fig 1A). Full-length PfPDEβ protein was also detected in early and late ring
stages (S2D Fig). Further IFA experiments showed that in early schizonts, PDEβ colocalises
with the endoplasmic reticulum (ER)–resident protein plasmepsin V (Fig 1B). We then used
the PKG inhibitor Compound 2 and the cysteine protease inhibitor E64 in parallel to examine
the localisation by IFA of PDEβ at two stages of late schizont development. Compound 2
blocks development of fully segmented schizonts with all the surrounding membranes intact.
E64 blocks schizont development at a slightly later stage when the parasitophorous vacuole
membrane (PVM) has ruptured (Fig 1C). This approach revealed a dual localisation for PDEβ
consistent with a distinct apical signal predominant in Compound 2–arrested schizonts and a
pattern reminiscent of a plasma membrane or inner membrane complex (IMC) localisation in
E64-arrested schizonts and in free merozoites (Fig 1B). Both localisation patterns were also
observed in unblocked schizonts (S2E Fig). These data, combined with the prediction that
PDEβ is an integral membrane protein, suggest that the PDEβ is transported via the ER to an
apical location (presumably a secretory apical organelle) and then subsequently discharged to
the plasma membrane of individual merozoites within mature schizonts.
Previously reported work using recombinant PfPDEα [22, 23] and gene knockout studies
on PfPDEδ [21] as well as P. berghei PDEδ [6] and P. yoelii PDEγ [9] detected only cGMP
hydrolytic activity associated with these three isoforms, with no evidence attributing cAMP
hydrolytic activity to any of these malaria parasite PDEs. To establish whether PDEβ is capable
of hydrolysing cAMP, we immunoprecipitated the protein from PfPDEβHA schizont extracts
via its epitope tag, followed by a PDE activity assay. This clearly demonstrates that PDEβ is a
dual-specific PDE that is able to hydrolyse both cAMP and cGMP in vitro (Fig 1D). We con-
clude that PDEβ is likely the only blood stage PDE with cAMP-hydrolysing activity.
PDEβ is essential for asexual blood stage parasite viability
To examine the function and essentiality of PDEβ, we used a conditional system employing a
rapamycin (RAP)–inducible, dimerisable Cre recombinase (DiCre [28]) to disrupt the PfPDEβ
Phosphodiesterase beta underpins cAMP signalling in malaria parasites
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gene. We first modified the gene by homologous recombination to introduce loxP sites flank-
ing exons 7 to 9, encoding the catalytic domain of the enzyme to produce the conditional
knockout line PfPDEβΔcatHA. PCR analysis of PfPDEβΔcatHA confirmed the desired gene modi-
fication and also demonstrated RAP-induced excision of the floxed PfPDEβ sequence (Fig 2A
and 2B). Ablation of expression of the haemagglutinin (HA)–tagged PDEβ catalytic domain
following RAP treatment of synchronous ring-stage cultures was confirmed at the protein
Fig 1. PfPDEβ is a dual-specific PDE that translocates from an apical location to the merozoite plasma membrane. (A) Western blot showing a
time course of PfPDEβ-HA expression in the Plasmodium falciparum blood stage cycle. Parasites were harvested at the indicated hours post
invasion (hpi). Equal parasite numbers were loaded in each lane. Positions of molecular weight markers are indicated. (B) Colocalisation in
schizonts by IFA (following inhibitor treatment, left) of PfPDEβ-HA (red) with markers of specific subcellular compartments (green): plasmepsin V
(PMV; ER marker), AMA1 (microneme marker), GAP45 (IMC marker), and MSP119 (plasma membrane marker). Nuclear material was visualised
by DAPI staining (blue). Merged red and green channels are shown (merge) and a DIC microscopy image is shown to the right. Scale bar, 5 μm.
(C) Schematic showing the effects of Compound 2 and E64 on merozoite egress. (D) Hydrolytic activity (fmol product/minute/mg substrate) of
PfPDE-HA affinity-purified from parasite extracts, using either cAMP or cGMP as substrate. Activity of control pull-downs from similarly prepared
extracts of wild-type P. falciparum (3D7) are also shown. Data are means from three biological replicates, each performed in triplicate. Error bars,
SEM. AMA1, apical membrane antigen-1; cAMP, cyclic AMP; cGMP, cyclic GMP; C2, Compound 2; DIC, differential interference contrast;
ER, endoplasmic reticulum; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; GAP45, glideosome-associated protein 45; HA, haemagglutinin;
hpi, hours post invasion; IFA, immunofluorescence assay; IMC, inner membrane complex; MSP119, merozoite surface protein 119; PDE,
phosphodiesterase; PfPDEβ, Plasmodium falciparum phosphodiesterase beta; PMV, plasmepsin V.
https://doi.org/10.1371/journal.pbio.3000154.g001
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Fig 2. Rapid and efficient conditional disruption of PfPDEβ expression. (A) Schematic of the strategy used for generating a conditional PfPDEβ
knockout line (PfPDEβΔcatHA) by incorporating loxP sites (yellow boxes) flanking the recodonised catalytic domain (hatched box), a triple HA tag
(red), and a hdhfr selection cassette (grey) into the PfPDEβ locus of the DiCre-expressing Plasmodium falciparum line 1G5DC. Black arrows denote
promoters and lollipops represent transcription terminators. The relative positions are shown of PCR amplicons (black bars) used to confirm the
absence of wild-type locus (WT), or correct plasmid integration (INT; introduced by single crossover homologous recombination) into the PfPDEβ
locus, or RAP-induced excision (EXC) of the floxed sequence. (B) Diagnostic PCR analysis of the PfPDEβ locus in the parental 1G5DC line and the
Phosphodiesterase beta underpins cAMP signalling in malaria parasites
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level by western blot (Fig 2C) and IFA (Fig 2D). Quantification of anti-HA positive schizonts
was used to determine the excision rate, which was 95.5% (±3%) (Fig 2E).
The morphology of PfPDEβΔcatHA parasites prior to treatment with RAP was indistinguish-
able on microscopic analysis of Giemsa-stained blood films from that of the 1G5DC parental
line parasites. Similarly, no discernible differences in morphology were detected between
RAP- and mock-treated PfPDEβΔcatHA parasites up to and including the fully segmented schiz-
ont stage in the excision cycle (cycle 0) (Fig 3A). Consistent with this, there were no detectable
differences in the DNA content of schizonts or the numbers of nuclei per schizont (Fig 3B and
3C). Taken together, these data clearly show that truncation of PfPDEβ at the ring stage does
not affect intracellular parasite development or schizont maturation in cycle 0.
Monitoring of parasite DNA replication and growth (Fig 3D) for more prolonged periods
of approximately 8 days (4 erythrocytic cycles) showed a significant reduction in parasite
growth in the RAP-treated cultures. PCR analysis of these cultures showed that PfPDEβ-null
parasites did not survive and were quickly outgrown by nonexcised parasites (Fig 3E). Further-
more, viable parasites cloned from these RAP-treated cultures never displayed an excised
PfPDEβ locus, indicating that these derived from a minor population of nonexcised parasites
(S3 Fig). Collectively, these results show that PDEβ plays an essential role in asexual parasite
growth.
Loss of PDEβ expression leads to a dramatic reduction in invasion and
rapid post-invasion death
To more precisely define the developmental stage in the erythrocytic cycle at which loss
of PDEβ exerted its effect, we next compared egress of mature RAP- or mock-treated
PfPDEβΔcatHA schizonts at the end of cycle 0. Analysis by western blot of release of the parasi-
tophorous vacuole (PV) protein serine repeat antigen 5 (SERA5) into the culture supernatant
(Fig 4A), or flow cytometry (S4A Fig) and time-lapse video microscopy (S1 and S2 Videos;
wild type and knockout, respectively), showed that PDEβ deletion had no effect on merozoite
egress. We have previously shown that addition of the PDE inhibitor, zaprinast, to mature P.
falciparum schizonts leads to elevated cGMP levels, which activates PKG and triggers merozo-
ite egress, and that this is blocked by addition of a PKG inhibitor (Compound 2 [1]). We have
also used this approach previously to show that addition of a PDE inhibitor to mature schiz-
onts triggers elevated cytosolic calcium levels and that, again, this is blocked by PKG inhibition
[5]. We used this approach (with zaprinast or 5-Benzyl-3-isopropyl-1H-pyrazolo[4,3-d]pyri-
midin-7(6H)-one [BIPPO], a more potent PfPDE inhibitor [29]) to test whether there is any
difference in calcium release in PDEβ knockout and wild-type parasites. Levels of cytosolic cal-
cium release were equivalent in PDE inhibitor-treated wild type and PDEβ null schizonts and
were PKG dependent (S4C Fig). These results indicate that deletion of PDEβ has no effect on
calcium mobilisation, which is required for merozoite egress.
PfPDEβΔcatHA line before and following RAP treatment. Amplification of an irrelevant target sequence used as a DNA quality control (ctrl). (C)
Western blot showing efficient ablation of PfPDEβ-HA protein expression in the schizont stage of the erythrocytic cycle (cycle 0), in which the
parasites were RAP treated. Antibodies to PKG and GAPDH were used to control for equal loading. (D) IFA showing the effects of RAP treatment
on PfPDEβ-HA protein expression. Cycle 0 schizonts were co-stained with anti-HA (green), anti-AMA1 (red), and DAPI (blue). Scale bar, 5 μm.
(E) The efficiency of PfPDEβΔcatHA disruption following RAP treatment was determined at the protein level by quantification of anti-HA positive
schizonts. Data presented are means from three independent excision experiments. Error bars, 1 SD. More than 100 schizonts were counted per
experiment and condition. �, significant by paired t test (p-value = 0.0002). Representative microscopy images taken at 40× magnification are shown
to the right. Anti-HA (yellow), and DAPI (cyan). Scale bar, 10 μm. AMA1, apical membrane antigen-1; ctrl, control; DiCre, dimerisable Cre
recombinase; Exc, excision; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; HA, haemagglutinin; IFA, immunofluorescence assay; INT,
integration; PfPDEβ, Plasmodium falciparum phosphodiesterase β; PKG, cGMP-dependent protein kinase; RAP, rapamycin; WT, wild-type.
https://doi.org/10.1371/journal.pbio.3000154.g002
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In contrast, flow cytometry of SYBR Green–labelled parasites showed a substantial reduc-
tion in invasion efficiency (71% ± 2.78%; n = 5) in the RAP-treated PfPDEβΔcatHA parasites
(Fig 4B and S4B Fig). Merozoites emerging from individual RAP- and mock-treated PfPDEβΔ-
catHA schizonts were followed by video microscopy to assess their competence to induce red
cell deformation, echinocytosis, and to conclude successful invasion. Rupture events from
RAP-treated schizonts showed a highly significant reduction in all three steps, suggesting that
Fig 3. PDEβ disruption has no impact on parasite development in the excision cycle but is lethal to long-term growth. (A) Images of Giemsa-
stained blood films showing the morphology of RAP-treated (+RAP) and mock-treated (DMSO) PfPDEβΔcatHA parasites at different points in the
excision cycle (cycle 0). Highly synchronised parasite cultures were treated whilst at ring stage. Scale bar, 5 μm. (B) DNA content analysis by flow
cytometry of cycle 0 PfPDEβ-null schizonts (red plots) compared with untreated schizonts (blue plots). Data representative of three experiments,
each performed in triplicate, are shown for each of the three time points. (C) Mean number of PfPDEβΔcatHA merozoites per schizont in cycle 0
following mock or RAP treatment. Data were derived from five independent experiments; a total of 100 schizonts were examined on DAPI-stained
blood films. Error bars, 1 SD. (D) Growth curves of the PfPDEβΔcatHA and 1G5DC parental lines following mock or RAP treatment, derived by
measuring parasite DNA content using SYBR Green fluorescence. Each data point is a mean value derived from two biological replicate
experiments, each performed in triplicate. Error bars, 1 SD. (E) Diagnostic PCR analysis of the PfPDEβ locus in mock and RAP-treated
PfPDEβΔcatHA cultures over six erythrocytic cycles of parasite replication, showing rapid loss of the signal diagnostic of the excised (PfPDEβ-null)
parasites (EXC). Primers used were as described in Fig 2a and 2b. CTRL, control; EXC, excised; hpi, hours post invasion; INT, integration; n.s., not
significant by unpaired t test (p-value = 0.9895); PDEβ, phosphodiesterase β; PfPDEβ, Plasmodium falciparum phosphodiesterase β; RAP,
rapamycin; RFU, relative fluorescence unit.
https://doi.org/10.1371/journal.pbio.3000154.g003
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Fig 4. PfPDEβ disruption leads to a severe invasion defect and rapid post-invasion death due to elevated parasite cAMP
levels. (A) Western blot analysis of culture supernatants from cycle 0 RAP-treated or DMSO-treated PfPDEβΔcatHA schizont
cultures over time. Supernatant samples were taken at the indicated times (minutes) following schizont purification. The blot was
probed for the soluble PV protein SERA5, a biomarker of merozoite egress. A quantification of band intensities from three
independent experiments is shown to the right. Analysis was performed using ImageJ software and values normalised to the
DMSO start sample (0’). Means are presented, with error bars representing the standard error of the mean. No significant
Phosphodiesterase beta underpins cAMP signalling in malaria parasites
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invasion by PDEβ-null merozoites is impaired upstream of tight junction formation (Fig 4C
and S3–S7 Videos; the first two are wild type and the last three are knockout). The subpopula-
tion (29%) of PfPDEβ-null parasites that were able to invade consistently gave rise to small,
apparently intracellular, merozoite-sized parasites with little or no development of a vacuole or
cytoplasm, suggesting a block in development immediately following invasion (Fig 4D). Anal-
ysis of the morphology of these dysmorphic intracellular parasites over time revealed that
pyknotic parasites were present from the first hour after invasion, whilst some parasites that
initially developed a vacuole appeared to rapidly shrink to condensed, dysmorphic forms (Fig
4D and S6A Fig). IFA using two different monoclonal antibodies reactive with distinct proteo-
lytic fragments of merozoite surface protein 1 (MSP1) showed that the majority of newly
appearing parasites were intracellular in mock- and RAP-treated cultures (S4D Fig), confirm-
ing that a proportion of PfPDEβ-null parasites were able to successfully enter erythrocytes.
Together, these results indicate that disruption of PDEβ function leads to approximately a 70%
reduction in merozoite invasion and that in the subpopulation of merozoites that successfully
invade an erythrocyte, subsequent early post-invasion development is prevented, leading to
parasite death prior to ring stage formation.
PDEβ disruption leads to a dramatic reduction in schizont cAMP and
cGMP hydrolytic activity and elevated cellular cAMP levels
To evaluate the impact of PfPDEβ ablation on overall PDE activity in the parasite, schizont
extracts were assayed for levels of cAMP and cGMP hydrolytic activity. Cyclic AMP-PDE
activity was reduced by approximately 11-fold in extracts of the PfPDEβ-null parasites (Fig
4E), with the small amount of residual cAMP-PDE activity likely being attributed to parasites
in which gene excision had not taken place. In contrast, cGMP-PDE activity was reduced by
only approximately 3.5-fold, with significant residual activity. These results confirmed that
PfPDEβ disruption leads to ablation of enzyme activity, and importantly were also consistent
with the analysis of immunoprecipitated PDEβ-HA described above in showing that PDEβ is a
dual-specific PDE enzyme capable of hydrolysing both cAMP and cGMP. The results also con-
firmed that there is at least one other PDE expressed in schizonts possessing cGMP-PDE activ-
ity, probably PDEα [22]. The results strongly suggest that there is no other asexual blood stage
PDE capable of hydrolysing cAMP. In support of this conclusion, whilst PDEβ disruption had
difference between the two conditions was detected for any time point by t test (n.s.). (B) Impact of PfPDEβ disruption on
erythrocyte invasion at the transition from cycle 0 to cycle 1. Invasion efficiency was measured using FACS to compare ring
stage parasitaemias obtained from DMSO- and RAP-treated PfPDEβΔcatHA culture. Data are means from five biological
replicates, each performed in triplicate. Error bars, 1 SD. �, significant by paired t test (p-value< 0.0001). (C) Individual schizont
rupture events from RAP (n = 21) and mock-treated (DMSO, n = 17) PfPDEβΔcatHA cultures were followed by video microscopy
and scored for the number of merozoites inducing erythrocyte deformation (left), the number of erythrocytes undergoing
echinocytosis (middle), and the number of successful invasion events (right). �, significant by unpaired t test (p-value<0.001).
(D) Quantification of parasite morphology in cycle 1, determined by microscopic examination of Giemsa-stained blood films
taken at different hpi. Parasites from RAP (+)- and mock (−)-treated PfPDEβΔcatHA cultures were counted and scored according
to their morphology: normal morphology (green), delayed in development (dark grey), condensed/pyknotic (light grey).
Examples of each category and time point are shown in the left panel. Scale bar, 5 μm. Data are means from two independent
experiments, independently scored by two researchers. Error bars, 1 SD. At least 300 parasites were scored at each time point and
condition. (E) cAMP and cGMP hydrolytic activity (pmol min−1 per mg parasite protein) measured in membrane preparations of
mature cycle 0 DMSO or RAP-treated PfPDEβΔcatHA schizonts. Data are means from five biological replicates, each carried out in
triplicate. Error bars, 1 SD. �, significant by Welch-corrected t test (p-value< 0.0001). (F) Fold changes in cellular levels of cAMP
and cGMP in mature cycle 0 DMSO or RAP-treated PfPDEβΔcatHA schizonts. Data are from eight biological replicates, each
performed in duplicate. Error bars, SEM. �, significant by Welch-corrected t test (p-value 0.0065); n.s., not significant (p-value
0.3155). cAMP, cyclic AMP; cGMP, cyclic GMP; cNMP, cyclic nucleotide monophosphate; FACS, fluorescence-activated cell
sorting; hpi, hours post invasion; n.s., not significant; PDE, phosphodiesterase; PfPDEβ, Plasmodium falciparum
phosphodiesterase β; PV, parasitophorous vacuole; RAP, rapamycin; SERA5, serine repeat antigen 5.
https://doi.org/10.1371/journal.pbio.3000154.g004
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no significant effect on cGMP levels in parasite extracts, it resulted in a 3-fold increase in intra-
cellular cAMP levels (Fig 4F). This result provides further confirmation that there is no other
PDE capable of regulating cAMP levels in P. falciparum schizonts, whereas cGMP levels can
still be regulated in the absence of PDEβ. The unchanged cGMP levels are consistent with the
absence of an egress phenotype in the PDEβ knockout line, as egress is known to be regulated
by PKG.
Phosphoproteome analysis of PfPDEβ-null schizonts reveals
hyperactivation of PKA
We reasoned that the deleterious effects of PfPDEβ disruption on parasite viability might be
due to the elevated levels of intracellular cAMP leading to increased phosphorylation of para-
site proteins by the parasite PKA. To address this, we first examined extracts of mock- and
RAP-treated PfPDEβΔcatHA schizonts by western blot with an antibody specific to phosphory-
lated PKA consensus motifs R, R/K, X, pS/pT (where R is arginine, K is lysine, X is any amino
acid and pS or pT denote phosphorylated serine or threonine). PDEβ disruption resulted in an
increased number and intensity of antibody-reactive polypeptides, suggesting that the phos-
phorylation was a result of cAMP-induced ‘hyperactivation’ of PKA following PDEβ disrup-
tion (Fig 5A).
To gain insights into candidate proteins underpinning the PfPDEβ-null phenotype and to
identify the full complement of putative PKA substrates that become phosphorylated upon
PfPDEβ disruption, we carried out quantitative mass spectrometric global phosphoproteome
analysis of mock- and RAP-treated PfPDEβΔcatHA schizonts. Our strategy incorporated PKG
inhibition (with Compound 2) to ensure that all the schizonts used for the analysis were syn-
chronised precisely at the point when PKG activity is required for merozoite egress. PKG inhi-
bition also allowed us to distinguish between sites phosphorylated by PKA and PKG, because
in other species their consensus substrate sequences are very similar [30]. A total of 5,374
phosphosites were identified, distributed over 1,326 proteins (1,192 P. falciparum and 134
Homo sapiens proteins). Of these, 893 sites were significantly different (Welch unpaired t test)
between the RAP- and mock-treated samples (Fig 5B left panel and S1 Table), with 341 sites
being reduced and 537 sites increased in the knockout. A total of 255 sites were changed
by>2-fold, with 239 exhibiting a>2-fold increase but only 16 being decreased by>2-fold in
the PDEβ knockout, 7 of which were from the PDEβ N-terminal domain, strongly suggesting
that excision of the catalytic domain results in expression of an unstable truncated form of
PfPDEβ.
Unphosphorylated peptides present in the phosphopeptide-enriched sample were quanti-
fied to show that the vast majority of the 3,170 (2,953 P. falciparum and 217 H. sapiens) identi-
fied proteins were unchanged in abundance in RAP- and mock-treated PfPDEβΔcatHA
schizonts (Fig 5B right panel and S2 Table). Only eight proteins were significantly less abun-
dant (Welch unpaired t test) in the PfPDEβ-null sample, with PfPDEβ itself (2.7-fold) showing
the greatest change. The abundance of human dihydrofoate reductase (hDHFR), used as a
drug-resistance selection marker during modification of the PfPDEβ locus, was also signifi-
cantly reduced in RAP-treated samples; this was as expected because the gene is excised
together with the PfPDEβ catalytic domain upon activation of DiCre (Fig 2A). Two of the
few proteins showing a significant increase in abundance in the PfPDEβ-null sample were
human proteins, FK506-binding protein 1A (FKBP1A) (1.96-fold) and mechanistic target of
rapamycin (mTOR) (2.93-fold). These correspond to the RAP-binding fusion partners used
in the DiCre system [28], so this finding is consistent with RAP binding enhancing their
stability.
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Fig 5. Phosphoproteome analysis shows up-regulation of PKA-mediated phosphorylation in PfPDEβ-null schizonts. (A) Western blot analysis
of DMSO- and RAP-treated mature cycle 0 PfPDEβΔcatHA schizonts, probed with antibodies specific for the phosphorylated generic consensus PKA
substrate motif. The blot was reprobed with an anti-HA antibody to monitor disruption of PfPDEβ-HA expression, as well as an antibody to MyoA
as a loading control. (B) Changes in phosphorylation and protein abundance between RAP-treated (PfPDEβ-null, KO) and mock-treated (WT)
Compound 2–arrested PfPDEβΔcatHA schizonts. Left panel: peptide intensity (log10) plotted against log2 fold change for 5,374 phosphosites, with
significantly altered sites (Welch-corrected t test) in dark grey. Seven phosphosites from the PDEβ N-terminal domain (red) and four significantly
up-regulated phosphosites in ACβ and CDPK1 (green), as well as MyoA and AMA1 (blue), are highlighted. Right panel: changes in protein
Phosphodiesterase beta underpins cAMP signalling in malaria parasites
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Among the phosphosites significantly increased in the PDEβ knockout, we found a highly
significant enrichment in motifs with R or K in the -2 position or -2 and -3 positions relative
to the phosphorylation site, resembling mammalian consensus PKA substrate sequences (Fig
5C, S3 Table, and S5 Fig).
Approximately 52% (279/537) of the significantly up-regulated phosphosites and 63% (151/
239) of phosphosites increased by>2-fold conform to the minimal PKA consensus motif R/K,
x, pS/pT, consistent with hyperactivation of the enzyme in the absence of PfPDEβ (Fig 5B and
S5 Fig). It is therefore likely that these data define the P. falciparum consensus PKA substrate
sequence motif (Fig 5C). A 1D rank-based annotation analysis found different variations of K/
R, K/R, x, S/T to be the most highly enriched motifs in the PDEβ knockout sample, with RRxS
(where R is arginine, x is any amino acid and S is serine) occupying the top rank (Fig 5D and
S3 Table). Although the canonical R in position -2 seems to be slightly more enriched, phos-
phosites with a K in the -2 position, if paired with any basic residue in the -3 position, were
also highly enriched. Phosphosites with a K in the -2 position were generally more frequent,
which may be a consequence of the A/T-rich P. falciparum genome. The P. falciparum PKA
may have evolved to better accommodate such K-rich substrates.
Gene ontology (GO) analysis revealed that PfPDEβ disruption led to dysregulated phos-
phorylation of proteins involved in a range of cellular processes, including chromatin remodel-
ling, transcription, RNA metabolism, translation, and ubiquitination. A number of proteases,
ATPases, ion transporters, and signalling components also showed significant changes in
phosphorylation. Furthermore, significant changes were found in components of the parasite-
specific glideosome as well as rhoptry- and microneme-associated proteins. PKA consensus
motifs were overrepresented in the phosphosites up-regulated in the PfPDEβ knockout in
these functional groups (Fig 5E and S4 Table). Examination of GO term enrichment, using
Gene Ontologizer software, identified significant enrichment of only two GO terms in the sig-
nificantly down-regulated phosphosites. These were the Biological Process, ‘Ion transport’,
and the Cellular Component, ‘Inner membrane pellicle complex’. This reflects a detectable
reduction in phosphorylation of significant numbers of proteins within just these two catego-
ries in the presence of elevated cAMP levels. One possible explanation for this is that PKA may
selectively activate a protein phosphatase to dephosphorylate a restricted number of proteins.
A previous global phosphoproteome of P. falciparum schizonts showed that 425 of the 2,541
unique phosphosites resembled a consensus PKA sequence, suggesting an important role for
this kinase at this life cycle stage [31]. We previously identified 98 P. falciparum schizont phos-
phosites that were regulated in a PKG-dependent manner [3]. Interestingly, 46% of these sites
were also differentially regulated in the PDEβ knockout (in the presence of a PKG inhibitor),
supporting a functional link between the two pathways (S1 Table). Both the P. falciparum ade-
nylyl cyclase β (PfACβ) and PfPDEβ had a single PKG-dependent phosphorylation site (S1572
abundance, with PfPDEβ, hDHFR, mTOR, and FKBP1A highlighted. (C) Sequence logo showing consensus sequence surrounding phosphosites
(position 0) significantly increased in the PfPDEβ-null samples. (D) Motif analysis showing the six motifs most enriched in the PfPDEβ-null
samples by 1D annotation analysis (green) and two control kinase motifs (red). CDPK1 and CRK4 motifs used are described in Materials and
methods. Data show mean log2 fold changes. Error bars, SEM. Numbers in parentheses denote the frequency of the occurrence of the motif in
phosphosites significantly up-regulated in the PfPDEβ-null/total number of phosphosites with that motif. (E) Presentation of GO terms
dysregulated in PfPDEβ-null schizonts. Bars show numbers of phosphosites up- (green) and down-regulated (red) in the PfPDEβ-null schizonts
compared with wild type. Light shades denote sites significantly different by Welch t test, and bright colours denote sites>2-fold changed. Hatched
bars mark phosphosites with a minimal PKA consensus motif (K/R, x, S/T). The numbers of proteins in each group are indicated on the right. ACβ,
adenylyl cyclase β; AMA1, apical membrane antigen-1; CDPK1, calcium-dependent protein kinase 1; CRK4, cdc2-related protein kinase 4;
FKBP1A, FK506-binding protein 1A; GO, gene ontology; HA, haemagglutinin; hDHFR, human dihydrofolate reductase; KO, knockout; K/R,
lysine/arginine; mTOR, mechanistic target of rapamycin; MyoA, myosin A; PDEβ, phosphodiesterase β; PfPDEβ, Plasmodium falciparum
phosphodiesterase β; PKA, cAMP-dependent protein kinase; RAP, rapamycin; S/T, serine/threonine; WT, wild type; x, any amino acid; 1D, one-
dimensional.
https://doi.org/10.1371/journal.pbio.3000154.g005
Phosphodiesterase beta underpins cAMP signalling in malaria parasites
PLOS Biology | https://doi.org/10.1371/journal.pbio.3000154 February 22, 2019 12 / 32
and S156, respectively [3]), which points to a potential mechanism for the regulation of cAMP
levels by PKG. Calcium-dependent protein kinase 1 (CDPK1) was identified as a likely direct
PKG substrate in the previous study, in which it was phosphorylated at position S64. However,
in the PDEβ knockout schizonts, an alternative CDPK1 phosphosite (Y44) was up-regulated
>4-fold (Fig 5B), although which kinase performs this tyrosine phosphorylation event is not
known. This also raises the question of whether a second spike of calcium release is required
post-egress, as previously implied [32–34].
The requirement for PKG activity upstream of PKA activation is bypassed
in PfPDEβ-null parasites
To seek biological validation of the list of potential PKA substrates, we focused on the phos-
phosite identified in P. falciparum myosin A (PF3D7_1342600), MyoA S19 (increased by
2.6-fold in the PDEβ knockout). MyoA is a component of the so-called glideosome, a complex
of parasite proteins involved in actinomyosin-based motility and host cell invasion [35]. We
have previously shown that phosphorylation of MyoA S19 in mature wild-type P. falciparum
schizonts is dependent on PKG activity, as treatment with the PKG inhibitor Compound 2
drastically reduces phosphorylation of this residue [3]. However, another study [36] suggested
that phosphorylation of MyoA S19 is carried out by PKA.
To investigate whether MyoA S19 is phosphorylated by PKA or by PKG, we blocked PKG
activity (and schizont rupture) in PfPDEβ knockout and control parasites with Compound 2.
MyoA S19 phosphorylation was not detected in Compound 2–blocked control schizonts, con-
sistent with this being a PKG-dependent event. Surprisingly, however, MyoA S19 phosphoryla-
tion was abundant in Compound 2–treated PfPDEβ-null schizonts (Fig 6A), strongly arguing
for this phosphorylation event being PKG independent in the absence of PfPDEβ. In contrast,
MyoA S19 phosphorylation accumulated in both control and PfPDEβ-null schizonts incubated
with the cysteine protease inhibitor E64, which prevents schizont rupture downstream of PKG
activation, confirming that MyoA S19 phosphorylation occurs just prior to or at egress (Fig
6A). Levels of MyoA S19 phosphorylation in E64-blocked wild-type schizonts were sensitive to
the PKA inhibitor H89 in a dose-dependent manner (Fig 6B), consistent with this phosphory-
lation event being mediated by PKA. In contrast, treatment of Compound 2–blocked wild-
type schizonts with the PDE inhibitor BIPPO [29] resulted in concentration-dependent
enhancement of MyoA S19 phosphorylation, phenocopying the PfPDEβ-null mutant (Fig 6C).
PKG regulates egress upstream of calcium release [1, 37]. To address the sequence of events
and relationship of cGMP, cAMP, and calcium signalling with respect to phosphorylation of
MyoA, we investigated the effect of the membrane-permeable calcium chelator BAPTA-AM
(1,2-bis(o-aminophenoxy)ethane-N,N,N0,N0-tetraacetic acid-acetoxymethyl ester) on MyoA
S19 phosphorylation. BAPTA-AM severely reduced MyoA S19 phosphorylation in Compound
2–treated PfPDEβ knockout schizonts as well as in E64-blocked wild-type and PfPDEβ knock-
out schizonts. This indicates that calcium signalling is also required for this phosphorylation
event (Fig 6D). It is therefore possible that MyoA19 could be phosphorylated by a calcium-
dependent protein kinase. Collectively, our results suggest that, although phosphorylation of
MyoA S19 is PKG dependent, ablation of PDEβ can bypass the need for PKG activity because
of the resulting elevated cAMP levels. Further work will be needed to determine whether
MyoA S19 can be phosphorylated directly by PKA and/or a CDPK in vivo. Interestingly, in the
related parasite T. gondii, MyoA S21, which may be functionally equivalent to P. falciparum
MyoA S19, has been linked to parasite motility and host cell egress and invasion [38, 39]. Our
results therefore suggest that PKG governs cAMP levels as well as PKA activation and that pre-
mature phosphorylation of MyoA S19 by PKA could lead to premature activation of the
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Fig 6. Deletion of PfPDEβ bypasses the need for PKG activity upstream of MyoA S19 phosphorylation in mature schizonts and results in
premature proteolytic shedding of AMA1. (A) PKG-independent phosphorylation of MyoA in PfPDEβ-null parasites. Western blot of PKG
inhibitor–treated (+C2) and E64-treated PfPDEβΔcatHA schizont proteins from DMSO- and RAP-treated PfPDEβΔcatHA cultures, probed with
a phospho-S19 MyoA antibody. The blot was reprobed with a polyclonal anti-MyoA antibody to determine the relative amounts of MyoA
present in each sample. The lower panel shows total protein levels in the gel prior to blotting. The schematic shows the effect of various
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actomyosin motor. This may contribute to the severe invasion phenotype observed in PDEβ-
null parasites.
The invasion-related protein AMA1 is shed prematurely from PfPDEβ-null
merozoites
A second phosphosite that was significantly up-regulated (2.3-fold) in the PfPDEβ-null schiz-
ont phosphoproteome and that had previously been linked to PKA activity is S610 of apical
membrane antigen-1 (AMA1), a merozoite integral membrane protein that plays an essential
role in host cell invasion [40] and that is released onto the merozoite surface from apical secre-
tory organelles called micronemes in a strictly PKG-dependent manner [1]. The S610 phospho-
site lies within the short cytoplasmic domain of AMA1. Although the exact function of AMA1
phosphorylation remains unknown, it has been shown that the S610 modification is one of a
series of AMA1 cytoplasmic tail phosphorylation events needed for efficient AMA1 function
during invasion [11, 12]. It has also been reported that this event is a prerequisite for subse-
quent phosphorylation at T613 by the parasite glycogen synthase kinase (GSK3) and that both
events are required for invasion [12]. In the present study, we did not detect phosphorylation
of AMA1 T613 in PfPDEβ-null schizonts in which S610 phosphorylation is stimulated, although
it is possible that the PKG blockade included in our phosphoproteome analysis protocol pre-
vented this subsequent phosphorylation step. Comparative IFA analysis of mock- and RAP-
treated PfPDEβΔcatHA schizonts showed that AMA1 release remained PKG dependent in
PfPDEβ-null schizonts (Compound 2 block) and there was no significant difference in the pro-
portion of parasites exhibiting surface-localised AMA1 in the presence of E64, which blocks
the red blood cell membrane rupture step of egress but is permissive for AMA1 release (Fig
6E). However, examination of supernatants from schizont cultures rupturing in the absence of
red blood cells detected significantly more shed AMA1 in the PfPDEβ-null samples than in the
control, indicating increased levels of AMA1 cleavage (Fig 6F). We also detected increased
compounds on egress: Compound 2 and BAPTA-AM block egress upstream of PVM rupture, BIPPO induces egress, and E64 prevents
erythrocyte plasma membrane rupture. (B) The PKA inhibitor H89 inhibits MyoA S19 phosphorylation. Western blot analysis of E64-arrested
wild-type schizonts (mock-treated PfPDEβΔcatHA) treated with increasing concentrations of the PKA inhibitor H89. A sample was taken
before inhibitor addition (start) and a Compound 2–blocked sample served as negative control. Blots were probed with antibodies against
phospho-S19 MyoA, total MyoA, and GAPDH as a loading control. (C) The PDE inhibitor BIPPO induces MyoA phosphorylation. Western
blot analysis of Compound 2–arrested mock- or RAP-treated PfPDEβΔcatHA schizonts, following incubation with increasing concentrations of
the PDE inhibitor BIPPO. A sample was taken before inhibitor addition to show the absence of MyoA S19 phosphorylation (start). Blots were
probed with the same antibodies as in (B). (D) BAPTA-AM inhibits MyoA phosphorylation. Effects of BAPTA-AM on MyoA S19
phosphorylation in Compound 2–arrested (top panel) or E64-arrested (bottom panel) PfPDEβΔcatHA schizonts following mock or RAP
treatment. Western blots were additionally probed with the same antibodies as in B and C. (E) Dual-stained IFAs showing the cellular
distribution of AMA1 in RAP- and mock-treated (DMSO) PfPDEβΔcatHA schizonts. Schizonts were co-stained with an AMA1 antibody (red)
and a HA antibody (green) to detect the presence or absence of PfPDEβ. DAPI (blue) was used to visualise nuclear material. Scale bar, 5 μm.
The bar chart (right) shows quantitation of proportions of schizonts displaying apical or peripheral AMA1 staining in E64-arrested
PfPDEβΔcatHA schizonts. Data presented are from a representative experiment in which>50 schizonts per condition were counted by two
researchers. Error bars, 1 SD. (F) Western blot analysis of culture supernatants from RAP- and mock-treated PfPDEβΔcatHA purified schizonts
sampled over 90 minutes of culture. The blot was probed with antibodies specific for the micronemal proteins AMA1 and EBA175, as well as
SERA5, to measure schizont rupture. Positions of molecular weight markers are indicated (left). The blot is representative of at least three
independent experiments. (G) Quantitation of AMA1 shedding by IFA in merozoites released from RAP- and mock-treated PfPDEβΔcatHA
schizonts. Purified merozoites were stained with an antibody against the AMA1 ectodomain. Thumbnails show examples for translocated
(surface), shed (−), and micronemal (apical) AMA1 in green. Nuclei were stained with DAPI (blue). The bar charts show the mean
proportions of merozoites exhibiting surface (left) and apical (right) AMA1 staining for each condition. More than 100 merozoites were
counted by two researchers. Error bars, 1 SD. �, significant by unpaired t test (p-value = 0.005); n.s., not significant (p-value = 0.306). AMA1,
apical membrane antigen-1; BAPTA-AM, 1,2-bis(o-aminophenoxy)ethane-N,N,N0,N0-tetraacetic acid-acetoxymethyl ester; BIPPO, 5-Benzyl-
3-isopropyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one; EBA175, erythrocyte-binding antigen 175; GAPDH, glyceraldehyde 3-phosphate
dehydrogenase; HA, haemagglutinin; IFA, immunofluorescence assay; MyoA, myosin A; n.s., not significant; PDE, phosphodiesterase;
PfPDEβ, Plasmodium falciparum phosphodiesterase β; PKA, cAMP-dependent protein kinase; PKG, cGMP-dependent protein kinase; PVM,
parasitophorous vacuole membrane; RAP, rapamycin; SERA5, serine repeat antigen 5.
https://doi.org/10.1371/journal.pbio.3000154.g006
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amounts of shed forms of another micronemal invasion-related protein, erythrocyte-binding
antigen 175 (EBA175), in the PfPDEβ-null supernatant sample, whilst there was no difference
in levels of the PV protein SERA5 between the two samples, confirming that PfPDEβ disrup-
tion does not affect schizont rupture. Confirmation of enhanced AMA1 shedding in the
PfPDEβ-null mutant was obtained by IFA analysis of released merozoites, revealing a signifi-
cant decrease in the proportion of free PfPDEβ-null merozoites reactive with an antibody
against the AMA1 ectodomain (Fig 6G). These results suggest that proteolytic cleavage of
AMA1 may be increased as a result of enhanced PKA activity in the PfPDEβ-null mutant.
Shedding of AMA1 from the merozoite surface is predominantly mediated by the micronemal
membrane-bound subtilisin-like protease 2 (SUB2), and to a lesser extent through intramem-
brane cleavage by the rhomboid-like protease 4 (ROM4) [41–43]. The enhanced shedding of
AMA1 may result from enhanced SUB2 activity. Intriguingly, our global phosphoproteomic
analysis identified seven phosphosites in ROM4 elevated by greater than 2-fold following RAP
treatment, four of which conform with the PKA consensus motif, and two adjacent residues in
SUB2 were also significantly changed. It remains to be shown whether any of these phosphory-
lation events regulate the activity of these proteases.
Absence of PfPDEβ activity in newly invaded parasites leads to prolonged
PKA activity, which interferes with early ring stage development
Activation of PKA at or around egress is thought to be essential for merozoite invasion [10, 11,
31]. Our results show that the requisite increase in cAMP levels is governed by PfPDEβ. How-
ever, nothing is known regarding the activity status of PKA following erythrocyte invasion. As
described above (Fig 4D), those PfPDEβ-null parasites that successfully invaded underwent
immediate developmental arrest, suggesting that PfPDEβ activity is also essential at this stage
of the life cycle. To further explore this finding, we examined the effects of treating early ring
stage wild-type parasites with the PDE inhibitor BIPPO. As shown in Fig 7A, BIPPO treatment
phenocopied the PfPDEβ-null post-invasion phenotype. Previous studies using BIPPO have
primarily investigated its effects on cGMP hydrolysis in apicomplexan parasites [18, 29]. Our
new results demonstrating that this inhibitor is able to target PDEβ show that it has the poten-
tial to affect both cAMP and cGMP hydrolysis in Plasmodium blood stages. Reasoning that
both the PfPDEβ-null and BIPPO-mediated phenotype are likely caused through elevated
cAMP or cGMP levels and inappropriate activation of the respective effector kinases PKA or
PKG, we examined whether we could rescue the PfPDEβ knockout and PDE inhibitor pheno-
type by treating early ring stages (0–2 h post-invasion) with PKG or PKA inhibitors. Survival
of PfPDEβ-null parasites was not significantly extended by the addition of either kinase inhibi-
tor (S6C Fig), presumably because they had been exposed to elevated cAMP levels over a long
period, causing extensive dysregulation and irreversible damage on multiple levels. In contrast,
treatment of wild-type ring stage parasites with the PKA inhibitor H89 partially reversed the
effects of BIPPO, resulting in normal ring stage development (Fig 7B and S6B Fig). Treatment
with the PKG inhibitor Compound 2 did not reverse BIPPO-mediated killing, clearly attribut-
ing the observed phenotype to elevated cAMP levels and untimely PKA activity (Fig 7B). To
further link the PfPDEβ-null and PDE inhibitor phenotypes to untimely PKA activation, we
treated ring stage parasites with BIPPO alone or in combination with kinase inhibitors. Total
parasite lysates analysed by western blot reveal a clear increase in reactivity, with an antibody
against phosphorylated PKA substrate motif in the BIPPO-treated sample. Addition of the
PKA inhibitor H89 reduced BIPPO-induced antibody reactivity to control levels, whereas the
PKG inhibitor Compound 2 did not, confirming that the post-invasion phenotype is likely due
to untimely PKA rather than PKG activity (Fig 7C).
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Future work will be needed to understand the dynamics of PDEβ function in blood stage
malaria parasites, how its translocation from an apical to a peripheral location impacts on the
regulation of local cyclic nucleotide levels, and how this might relate to the differential hydro-
lysis of cGMP and cAMP during merozoite egress and invasion.
Fig 7. Prolonged PKA activity in newly invaded PfPDEβ-null parasites blocks ring stage development. (A) The PDE inhibitor BIPPO
phenocopies the PfPDEβ-null post-invasion phenotype. Giemsa-stained blood films showing the morphology of PfPDEβΔcatHA parasites at different
time points in cycle 1, following either mock or RAP treatment of the parasites in cycle 0, compared to mock-treated parasites exposed to the PDE
inhibitor BIPPO immediately following invasion. (B) The PKA inhibitor H89, but not the PKG inhibitor Compound 2, rescues BIPPO-treated early
ring stages. The plots were generated by microscopic analysis of Giemsa-stained smears from ring stage cultures (18–22 hpi) treated with the
indicated compounds. Kinase inhibitors (H89 and C2) were added at 1–5 hpi and BIPPO at 2–6 hpi. Scale bar, 5 μm. Data presented are mean
counts (evaluated by three independent researchers) from two independent experiments, with>100 parasites counted per condition. Error bars,
SEM. �, significant by unpaired t test (p-value = 0.0005); n.s., not significant (p-value = 0.8508). (C) The PDE inhibitor BIPPO induces PKA-
dependent phosphorylation in ring stages. Western blot of total protein from ring stages (12–16 hpi) treated for 90 minutes with various inhibitors:
BIPPO (2 μM), H89 (30 μM), C2 (2 μM). Lane 1 = no inhibitor control, lane 2 = BIPPO only, lane 3 = BIPPO + H89, lane 4 = BIPPO + C2. The blot
was probed with an antibody to phosphorylated PKA substrate motif. The gel was stained for total protein prior to blotting to show equal loading
(right panel). BIPPO, 5-Benzyl-3-isopropyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one; hpi, hours post invasion; PDE, phosphodiesterase; PfPDEβ,
Plasmodium falciparum phosphodiesterase β; PKA, cAMP-dependent protein kinase; pS/pT, phosphoserine or phosphothreonine; RAP, rapamycin;
R/K, arginine or lysine.
https://doi.org/10.1371/journal.pbio.3000154.g007
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In conclusion, we have shown that PfPDEβ is a dual-function enzyme that is the only PDE
responsible for regulation of cAMP levels in blood stage malaria parasites. Ablation of
PfPDEβ results in hyperactivity of PKA, with the resulting dysregulated phosphorylation
leading to either complete loss of merozoite invasive capacity or lethal defects in parasite
development immediately post-invasion. We also provide the first direct genetic evidence for
PKA dependence of MyoA S19 and AMA1 S610 phosphorylation in P. falciparum. Several
licensed drugs (e.g., Roflumilast, Sildenafil, and Pentoxifylline) that target human PDEs are
widely used to treat a range of disorders [26, 44]. Our results revealing that PfPDEβ is essen-
tial for blood stage P. falciparum replication suggest that PDE inhibitors targeting this
enzyme could be developed as new antimalarial drugs, particularly if they also displayed
activity against the parasite PDEs expressed in gametocytes and pre-erythrocytic stages of the
parasite life cycle.
Materials and methods
Small molecules and antibodies
WR99210 was a kind gift from Jacobus Pharmaceuticals (New Jersey), RAP and the cysteine
protease inhibitor E64 were purchased from Sigma, the PKG inhibitor Compound 2 was
synthesised by MRC Technology (London, United Kingdom), the PKA inhibitor H89 was
obtained from TOCRIS Biosciences, the PDE inhibitor BIPPO [29] was a kind gift from Philip
E. Thompson (Monash University, Australia). Calcium chelators BAPTA-AM and Fluo-4 AM
were purchased from Thermo Fisher Scientific, and the calcium ionophore A23187 was from
Sigma-Aldrich.
Rat monoclonal anti-HA tag antibody (clone 3F10) and the same antibody conjugated to
agarose beads were purchased from Roche LifeScience. Rabbit anti-AMA1 antibody raised
against the ectodomain was described previously [45]. Rabbit anti-EBA175 is described in
[43]. Rabbit anti-GAP45 [46] and rat anti-MyoA antisera [3] were kind gifts from Judith
Green (The Francis Crick Institute, London, UK). Monoclonal mouse antibodies to MSP1-19
(2F10) and MSP1-83 (89.1) have been described previously [47, 48]. A mouse monoclonal
antibody to Plasmepsin V was a kind gift from Daniel E. Goldberg (Washington University
School of Medicine in St. Louis, USA). A mouse monoclonal antibody against PfGAPDH was
a kind gift from Claudia Daubenberger (SwissTPH, Basel, Switzerland), rabbit anti-SERA5 is
described in [49], rabbit anti-PKG antibody was from ENZO life sciences (New York), rabbit
anti pS19-MyoA phospho-antibody was raised against the phosphopeptide ‘N’-RRV[pS]
NVEAFDKC conjugated to KLH and double purified on the phosphopeptide, followed by
passing through its nonphosphorylated counterpart [3]. A rabbit monoclonal antibody specifi-
cally reacting with phosphorylated PKA substrate consensus motif (R,K/R,X,pS/pT) was pur-
chased from Cell Signaling Technology.
All fluorescently labelled secondary antibodies used were highly cross-adsorbed and either
conjugated to Alexa 488 (green) or Alexa 594 (red) (Molecular Probes).
Construction of the PfPDEβ-HA tagging and PfPDEβ conditional
knockout plasmid
A construct based on the pHH1_SERA5del3DC vector [28] was generated to C-terminally tag
the endogenous Pfpdeβ locus with a 3×HA tag. The construct contained a 0.9-kb 30 fragment
of the PfPDEβ gene, to facilitate single crossover recombination, fused to the HA tag. A loxP
site was placed downstream and the 30UTR of P. berghei DT. The construct also contained a
second loxP site and a hDHFR gene, which confers resistance to the antifolate WR99210. The
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resulting plasmid pPfPDEβ-HA was originally generated with the intention of conditionally
ablating PfPDEβ function by excision of the 30UTR flanked by loxP sites.
To create the PfPDEβ conditional knockout plasmid, a synthetic, partially recodonised
(Spodoptera frugiperda codon usage) PfPDEβ sequence was synthesised by GenScript. The
sequence comprised 1 kb of native P. falciparum PfPDEβ targeting sequence containing native
PDEβ sequence to drive recombination by single crossover, a loxP site inserted into intron 6
(of 8), and the remaining 819 bp of the PfPDEβ exonic sequence were recodonised to prevent
recombination downstream of the loxP site. A triple HA tag was added to the 30 end of the
sequence, followed by a stop codon. The synthetic PDEβ gene containing the internal loxP site
and the recodonised sequence was cloned into pPfPDEβ-HA, replacing the 0.9-kb fragment to
yield pPfPDEβΔcatHA.
P. falciparum culture and synchronisation
P. falciparum erythrocytic stages were cultured in human A+ erythrocytes (National Blood
Transfusion Service, London, United Kingdom) and RPMI 1640 medium (Lifetech) supple-
mented with 0.5% AlbuMAX type II (Gibco), 50 uM hypoxanthine, and 2 mM L-glutamine
according to standard procedures [50]. Tightly synchronised parasites were obtained by purifi-
cation of segmented schizonts on a 70% Percoll (GE Healthcare) cushion, addition of fresh
erythrocytes to allow invasion for 1 to 3 hours shaking, followed by another Percoll purifica-
tion to remove unruptured schizonts and sorbitol lysis of the pellet to obtain highly pure and
synchronous ring stages.
Transfection of P. falciparum blood stages
Genetic manipulation of P. falciparum parasites was carried out as previously described [4]. A
total of 80 μg of precipitated plasmid DNA was resuspended in 400 μL cytomix (120 mM KCl,
0.15 mM CaCl2, 2 mM EGTA, 5 mM MgCl2, 10 mM K2HPO4/KH2PO4, and 25 mM HEPES
[pH 7]). The DNA-cytomix solution was added to 250 μL of the packed ring stage cultures at
5% to 10% parasitaemia and the sample electroporated at 950 μF capacitance and a voltage of
0.31 kV using a GenePulser Xcell (Bio-Rad). Twenty-four hours later, the selection drug
WR99210 was added at 5 nM concentration. Once parasites were visible, the cultures were
cycled off the drug for 3 weeks, then on the drug until parasites reached 1% parasitaemia for
one to four cycles.
Limiting dilution to generate clonal parasite lines
Ring stage cultures were counted using a haemocytometer and diluted to give 0.25 parasites
per well in a 96-well plate at 2% haematocrit. Culture media was replaced every 3 days. After
14–21 days, positive wells were identified using a lactate dehydrogenase assay [51].
Integration and excision PCRs
Integration of the HA-tagging plasmid pPfPDEβ-HA into the Pfpdeβ (PF3D7_1321500) locus
was verified using primers Int F 50 GTTGAAAAGCAGTACAATAATGTTCCTTATC 30 and
Int R 50 CGGGATCATAAACCTCGATTG 30, and the following primers were used to detect
the WT locus and the absence of integration: WT R 50 GCCAAGTCGAATGGAAAGATAT
TG 30 and WT F 50 GTTGAAAAGCAGTACAATAATGTTCCTTATC 30. Integration of the
PDEβ loxP plasmid pPfPDEβΔcatHA into the same locus to create PfPDEβΔcatHA was confirmed
by PCR using primers specific for the integrated locus: int-F 50 GTTCTTCAAATGGTTGTG
TAAAATTAT 30 and int-R 50 GGCCAATGTCGTGGCAGATG 30. Cre recombinase–
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mediated excision of the PDEβ catalytic domain (exons 7 to 9) was monitored using primers
specific for the excised locus: exc-F 50 GTAATAAGAATGAATAGGCATATATGT 30 and
exc-R 50 TGAACATTGAAATTTGTATCCGTCT 30. The 30 end of the PDEβ coding region
unaffected by plasmid integration or Cre recombinase–mediated excision served as DNA qual-
ity and loading control: 30end-F 50 CAACTAAACCAATGTAATATTTT 30 and 30end-R 50
CGGGATCATAAACCTCGATTG 30. Primers int-F and 30end-R were combined to specifi-
cally amplify the wild-type locus.
SYBR Green growth assays
Synchronous ring stage cultures were adjusted to 0.5% parasitaemia, set up in 96-well flat-bot-
tom plates at 1% haematocrit, and triplicate samples frozen down daily for the duration of the
assay. Eventually, cells were lysed in 20 mM Tris, 5 mM EDTA, 0.008% saponin, 0.08% Triton
X-100, 1× SYBR Green I (Molecular Probes), pH 7.5 [52], and read in a fluorescent plate
reader at 485-nm excitation and 535-nm emission. Relative fluorescence units were normal-
ised based on the day 0 sample and plotted. To determine EC50 concentrations for inhibitors
used in this study, the same assay was conducted with 2-fold serial dilutions of the test com-
pounds in triplicate wells and termination of the assay after 72 hours.
Immunofluorescence microscopy
Dried blood films were fixed in 4% formaldehyde and permeabilised with 0.1% Triton X-100
in PBS. Blocking and antibody reactions were carried out in 3% bovine serum albumin in PBS
and washed with PBS. Slides were air-dried and mounted with ProLong Gold Antifade Moun-
tant containing DAPI (Thermo Fisher Scientific). Images were acquired on a NIKON Eclipse
Ti fluorescence microscope fitted with a Hamamatsu C11440 digital camera and overlaid in
ICY bioimage analysis software (icy.bioimageanalysis.org). Pure merozoites were obtained by
dual MACS (Miltenyi Biotec) purification. Rupturing schizont cultures were isolated on the
magnet, put back into culture for 45 minutes, then run through the MACS column again, and
the flowthrough containing merozoites was centrifuged at 3,500g for 5 minutes. Merozoite
preparations were smeared on glass slides, air-dried, and fixed with cold methanol. Blocking
and antibody reactions were carried out as described above.
Time-lapse video microscopy
Segmented schizonts were purified from RAP- or mock-treated PfPDEβΔcatHA cultures as
described above, introduced into custom-made viewing chambers [28], and imaged on a
Nikon Eclipse Ni-E widefield microscope with a Hamamatsu C11440 camera and a Nikon N
Plan Apo λ 100x/1.45NA oil immersion objective. For egress videos, images were taken at
5-second intervals over a total of 30 minutes. Individual egress events were cropped, trimmed,
and converted to video file format in ICY bioimage analysis software. For invasion videos,
images were taken every 150 ms for 8 minutes following schizont rupture and processed using
the Nikon NIS elements AR software. Merozoites from each rupture event were followed up
and scored for their ability to deform the host cell, induce echinocytosis, and complete
invasion.
Microscopy of Giemsa-stained blood films
Thin blood films were air-dried, methanol fixed, and stained with Giemsa’s azure-eosin-meth-
ylene blue (Merck) and imaged on an Olympus BX51 microscope fitted with an Olympus
SC30 digital colour camera through a 100× oil immersion objective.
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Quantification of PDEβ KO post-invasion death dynamics
RAP-mediated excision was performed on PfPDEβΔcatHA as described above, but treating 3/4
of the whole culture and leaving 1/4 for the control to adjust for the reduced invasion expected
in the PDEβ KO. Segmented schizonts from RAP- and DMSO-treated cultures were purified
and fresh erythrocytes added to allow invasion for 4 hours and obtain a ring stage parasitaemia
of 8% to 10% for both conditions. Giemsa-stained thin blood films taken at five different
time points spanning the whole intra-erythrocytic cycle were assessed blind by two different
researchers and parasites assigned to either of three morphological categories: normal mor-
phology, delayed, or pyknotic/condensed. More than 300 parasites were scored per time point
and condition.
Inhibitor treatments of early ring stages
Wild-type parasites (3D7) were synchronised to a 2-hour invasion window as described above
to obtain a pure culture with 7% to 10% ring stage parasitaemia. Kinase inhibitor treatments
were started at 2–4 hours post-invasion, 1 hour before addition of the PDE inhibitor BIPPO.
The PKA inhibitor H89 was used at 16.3 μM (approximately 1×EC50), the PKG inhibitor Com-
pound 2 at 1.5 μM (approximately 3×EC50), and the PDE inhibitor BIPPO at 1.2 μM (approxi-
mately 3×EC50). Giemsa-stained thin blood films taken at 19–21 hours post-invasion were
scored for their viability. More than 100 parasites per condition and experiment were counted
blind by three researchers each.
FACS analysis to measure DNA content, egress, and invasion
Parasite cultures were set up in triplicate wells per condition and fixed with 4% formaldehyde/
0.1% glutaraldehyde in PBS containing 1× SYBR Green I (Molecular Probes) for 30 minutes at
room temperature. Fixative was washed out with PBS and SYBR Green fluorescence read on a
BD LSR II Flow Cytometer (Becton Dickinson). Data were analysed using FlowJo 7 analysis
software (Becton Dickinson). For schizont DNA content analysis, the distribution of SYBR
Green fluorescence was displayed as a histogram. To analyse schizont rupture and ring stage
formation over time, schizontaemia and ring stage parasitaemia were calculated using high or
low SYBR Green fluorescence, respectively.
Parasite protein extraction, SDS PAGE, and immunoblotting
Parasites were released from host erythrocytes by saponin lysis and PBS-washed pellets resus-
pended in 2–3-pellet volumes of NP-40 lysis buffer (10 mM Tris, 150 mM NaCl, 0.5 mM
EDTA, 0.5% NP-40, pH 7.5, + cOmplete protease inhibitors [Roche]), incubated on ice for 10
minutes, and supernatants collected after centrifugation at 15,000g for 15 minutes at 4 ˚C.
Reducing SDS sample buffer was added and proteins separated on 4%–15% Mini-PROTEAN
TGX Stain-Free Protein Gels (Bio-Rad). Proteins were transferred to nitrocellulose mem-
branes in a Trans-Blot Turbo Transfer System (Bio-Rad) and blocked with 10% skimmed milk
in PBS/0.1% Tween-20. Antibody reactions were carried out in 1% skimmed milk in PBS/0.1%
Tween-20 and washed in PBS/0.1% Tween-20. Washed membranes were incubated with Clar-
ity Western ECL substrate (Bio-Rad) and exposed to X-ray film.
Egress assays
Schizonts were Percoll purified from synchronised PfPDEβΔcatHA cultures containing mainly
segmented schizonts and some young ring stages. Purified schizonts were resuspended in
RPMI, 100 uL aliquots distributed in 96-well plates, and assay started immediately. At different
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time points, culture supernatants were separated from parasite material by centrifugation fol-
lowed by purification through 0.22-μm Costar Spin-X centrifuge filters (Corning). Presence of
SERA5 in culture supernatants was quantified by western blot and used as a measure of schiz-
ont rupture. Western blots were probed with anti-AMA1 and anti-EBA175 antibodies to
detect differences in adhesin shedding dynamics.
Calcium release assays
Changes in the levels of intracellular free Ca2+ in response to PDE inhibitors were measured in
purified late schizonts. Schizonts were resuspended in warm Ringer buffer (122.5 mM NaCl,
5.4 mM KCl, 0.8 mM MgCl2, 11 mM HEPES, 10 mM D-Glucose, 1 mM NaH2PO4, pH 7.4) to
1–2 × 108 parasites/mL (25 μL packed cell volume per 1 mL Ringer buffer). A total of 2 μL of 5
mM Fluo-4 AM (Thermo Fisher) was added per 1 mL of parasite preparation. Cells were incu-
bated in the dark with Fluo-4 AM at 37 ˚C for 45 minutes. Cells were then washed twice in
warm Ringer buffer and incubated for 20 minutes to allow for de-esterification of the AM
ester. This was followed by a further two washes. The pellet was resuspended in Ringer buffer
at 1–2 × 108 parasites/mL and plated out on a 96-well plate.
Baseline Fluo-4 fluorescence in each well was read at 488-nm excitation and 525 emission
using a SPECTRAmax M3 microplate fluorimeter (Molecular Devices) preheated to 37 degrees
Celcius at 20-second intervals for a period of 3 minutes. The plate was removed from the
reader onto a heat block prewarmed to 37 ˚C, and cell suspensions were transferred to wells
containing test compounds to give the desired final concentrations (ionophore A23187
[20 μM], BIPPO [2 μM], zaprinast [100 μM], and Compound 2 [2 μM]). The plate was placed
back in the plate reader and read for a further 5 minutes at 20-second intervals. Relative fluo-
rescence units from individual reads were averaged and averaged baseline reads subtracted.
Results are presented as percentage of ionophore control.
Parasite lysate preparation for enzyme assays
Packed P. falciparum schizonts were obtained by saponin lysis and resuspended in ice-cold 5
mM Tris-HCl (with EDTA-free protease inhibitors), centrifuged repeatedly at 16,000g for 10
minutes at 4 ˚C, and the supernatant aspirated to remove residual RBC material until the
supernatant was clear. The pellet was then resuspended in 250 μL PDE lysis buffer (10 mM
Tris-HCl, pH 7.5, 150 mM NaCl, 0.5% Nonidet P-40, and EDTA-free protease inhibitors) per
50 μL of sample, incubated on ice for 30 minutes and centrifuged at 16,000g for 20 minutes at
4 ˚C. Supernatants were added to PDE assay.
Immunoprecipitation of PDEβ-HA
Pull-downs of the transgenic HA epitope–tagged PDEβ-HA were performed using the anti-
HA Affinity Matrix (Roche, 11815016001) that incorporates immobilised rat monoclonal anti-
body (clone 3F10). Packed parasite pellets were obtained by saponin lysis. The pellet was resus-
pended in 250 μL ice-cold PDE lysis buffer per 50 μL of sample, incubated on ice for 30
minutes with occasional mixing, and centrifuged as described above. The supernatant was
adjusted to 500 μL with PDE dilution buffer (10 mM Tris-HCl, pH 7.5, 150 mM NaCl, and
EDTA-free protease inhibitors) to give a final detergent concentration of less than 0.2%, and
the pellet discarded. A total of 20 μL of the matrix was washed twice with dilution buffer (cen-
trifuged at 30 seconds 13,000g to pellet the matrix) to equilibrate the anti-HA affinity matrix.
The lysate sample was then added to the equilibrated anti-HA affinity matrix, and incubated at
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RT for 2 hours with constant mixing. After incubation, the matrix was pelleted at 13,000g and
the supernatant removed. The beads were washed twice with ice-cold dilution buffer and were
added to the PDE assay.
PDE assays
PDE activity in P. falciparum particulate fractions and pull-down assays was measured by a
scintillation proximity assay (SPA) using yttrium silicate–based SPA beads (Perkin Elmer,
RPNQ0150). Scintillant is incorporated into beads, which bind to the primary phosphate
groups of noncyclic 50AMP or GMP, and the assay relies on the fact that cAMP and cGMP are
unable to bind. Assays were carried out in flexible 96-well plates (Perkin Elmer, 1450–401) in a
100-μL volume. A total of 90 μL of protein sample diluted in PDE assay buffer (50 mM Tris-
HCl, 8.3 mM MgCl2, and 1.7 mM EGTA) was added to each well, and 10 μL of a cNMP dilu-
tion (5 μL of [3H] cNMP tracer [Perkin Elmer cAMP-NET275250UC, cGMP-NET337250UC]
in 995 μL PDE assay buffer) was added to start the reaction. Plates were incubated at 37 ˚C
for 1 hour. Reactions were terminated by addition of 50 μL of resuspended PDE SPA beads
(reconstituted to 20 mg/mL in distilled H2O). Plates were sealed with Plateseal (Perkin Elmer)
briefly shaken and then incubated for 20 minutes at RT to allow the beads to settle. Scintilla-
tion was measured using a Wallac 1450 Microbeta Counter (Perkin Elmer) for 30 seconds. An
initial dose-response assay was performed with doubling dilutions of the sample to ensure the
substrate was not depleted during the course of the assay. The initial sample was diluted to
give roughly 30% hydrolysis of the cyclic nucleotide.
Measurement of intracellular cyclic nucleotide levels
Relative intracellular cAMP and cGMP in mature schizonts were measured using ELISA-
based FluoProbes high-sensitivity chemiluminescent assay kits (Interchim). Mature schizonts
were Percoll purified from RAP- or DMSO-treated PfPDEβΔcatHA cultures followed by saponin
lysis and two PBS washes. Parasite pellets were directly lysed in sample diluent for 10 minutes
at room temperature, centrifuged at 20,000g for 15 minutes, and the supernatant collected and
diluted 1:5 in sample diluent. Samples and cyclic nucleotide standards were acetylated accord-
ing to the manufacturer’s high sensitivity protocol. Standards and samples were run in tripli-
cates on the same plate and luminescence read with a Spectramax M3 plate reader. The
standard was fitted to a sigmoidal curve and used to determine cyclic nucleotide concentra-
tions in parasite samples.
Global phosphoproteomics and proteomics
The PfPDEβΔcatHA line was synchronised to a 2-hour invasion window, as described above, to
obtain 5×108 ring stages. The culture was split into two, and one half was treated with 100 nM
RAP and the other with vehicle (DMSO). RAP and DMSO were washed out 3 hours later.
Schizonts were Percoll purified 40 hours post-invasion and grown for a further 8 hours in the
presence of 1.5 μM PKG inhibitor Compound 2. Fully segmented schizonts were then har-
vested and host erythrocytes lysed with 0.15% saponin (Sigma) in the presence of complete
protease inhibitors (Roche) and washed twice in PBS plus protease inhibitors, snap-frozen and
stored at −80 ˚C. Parasite proteins were extracted with 10 volumes of 9 M urea in 50 mM
HEPES, pH 8.5, containing benzonase (Sigma) at 100 units/mL. Lysates were sonicated with a
probe sonicator (three bursts of 15 seconds on ice), centrifuged at 15,000g for 30 minutes at
4 ˚C, and protein content determined by a Bradford protein assay. A total of 1.05 mg of each
protein sample was reduced by 5 mM dithiothreitol, alkylated with 10 mM iodoacetamide,
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and quenched with 7.5 mM dithiothreitol. Samples were diluted with 50 mM HEPES to reduce
the urea concentration to<2 M prior to trypsin digestion. Peptides were desalted using a C18
Sep-Pak cartridge under vacuum, each sample divided into three (3 × 350 μg), and dried. Sam-
ples were resuspended in 50 mM HEPES and 30% (v/v) acetonitrile, and the corresponding
TMTsixplex (0.8 mg) label (resuspended in anhydrous acetonitrile) was added (TMT6-126,
-127, -128 to +RAP; TMT6-129, -130, -131 to DMSO). Hydroxylamine was added to quench
the reaction, and the samples were mixed and desalted using a C18 Sep-Pak cartridge. Dried
peptide mixtures were resuspended in 1 M glycolic acid + 80% acetonitrile + 5% trifluoroacetic
acid and added to titanium dioxide beads (5:1 [w/w] beads:protein), washed under acidic pH,
and eluted from the beads by adding 1% ammonium hydroxide followed by 5% ammonium
hydroxide, and dried by vacuum centrifugation. One third of the material was desalted with
the use of a C18 Stage Tip, and the other two thirds was fractionated and desalted by the use of
a Pierce High pH Reversed-Phase Peptide Fractionation Kit.
An Orbitrap Fusion Lumos was used for data acquisition. Desalted phosphopeptide mix-
tures were resuspended in 25 μL 0.1% trifluoroacetic acid and injected twice (10 μL per injec-
tion); high-pH fractionated phosphopeptide mixtures were resuspended in 15 μL 0.1%
trifluoroacetic acid and injected once (10 μL). Each run consisted of a 3-hour gradient elution
(75 μm × 50 cm C18 column), with higher-energy collision dissociation (HCD) being the
selected activation method. MaxQuant [53] (version 1.5.2.8) was used for all data processing.
The data were searched against UniProt extracted H. sapiens and P. falciparum proteome
FASTA files. A decoy database containing reverse sequences was used to estimate false discov-
ery rates and the false discovery rate was set at 1%. Default MaxQuant parameters were used
with the following adjustments: reporter ion MS2 with the sixplex TMT isobaric labels was
selected, Phospho(STY) was added as a variable modification, and ‘Filter labeled amino acids’
was deselected. Protein levels (MaxQuant ProteinGroups) were calculated from nonpho-
sphorylated material quantified in the phosphopeptide-enriched sample. The mass spectrome-
try proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE
[54] partner repository with the dataset identifier PXD009157. CDPK1 and CRK4 substrate
motifs used as controls were combinations of motifs proposed previously [55, 56]. Individual
motifs are shown in S5 Fig.
Data analysis
All graphs were created using GraphPad Prism7 and statistical significance tests performed in
the same software.
Statistical significance tests on phosphoproteome data (Welch t test with S0 = 0.2, permuta-
tion-based FDR set to 0.05 and 250 randomisations), motif analyses, 1D rank-based annota-
tion enrichment [57], scatterplots, and all matrices were created in Perseus 1.4.0.2.
Sequence logo was created using IceLogo (https://iomics.ugent.be/icelogoserver/) using all
5,374 phosphosites (31 amino acid sequence windows) identified in this study as the reference
dataset and all phosphosites significantly (Welch t test) increased in the PfPDEβ KO sample as
the experimental set.
GO enrichment analysis was performed on Gene Ontologizer (http://ontologizer.de/) using
the latest ontology and P. falciparum gene association files downloaded from http://www.
geneontology.org. Parent-Child-Union was used as the calculation method and p-values
adjusted using the Bonferroni correction. All gene IDs present in the phosphoproteome data-
set served as reference against gene IDs representing significantly changed phosphosites in the
PfPDEβ KO sample.
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Supporting information
S1 Fig. Alignment of the catalytic domains of selected human PDEs and the Plasmodium
falciparum PDEs. A total of 14 of the 15 residues (red) that are invariant amongst all of the 11
human PDE families are conserved in PfPDEβ. Additional residues identical in all the aligned
sequences are highlighted in grey. Human PDE catalytic domains representing either dual-
specific (HsPDE1, EAW96791), cAMP-specific (HsPDE4, NP_001032418), or cGMP-specific
(HsPDE9A, AAC39778) types are aligned with the catalytic domains of the four P. falciparum
PDEs. The 16 helical segments derived from studies on mammalian PDEs are depicted by col-
oured bars to reflect the three sub-domains: blue, NH2-terminal; orange, middle; and green,
COOH-terminal, defined previously [58]. Functional residues defined in mammalian PDEs
are indicated by the following: green ‘h’, hydrophobic clamp that binds the purine base; blue
‘m’, metal ion coordinating; red ‘n’, nucleotide recognition; and purple ‘c’, hydrolysis [59]. The
amino acid numbers are shown to the right of the sequences, and the total number of amino
acids in each protein is shown at the end in brackets. cAMP, cyclic AMP; cGMP, cyclic GMP;
COOH, carboxyl; NH2, amino; PDE, phosphodiesterase; PfPDEβ, Plasmodium falciparum
phosphodiesterase β.
(TIF)
S2 Fig. Generation of a PfPDEβ-HA line and tagged protein expression across the intra-
erythrocytic cycle. (A) Schematic showing the approach to C-terminally tag the endogenous
PfPDEβ gene with a 3×HA tag. The plasmid construct was transfected into a line expressing a
RAP-inducible Cre recombinase, upon activation of which the 30 untranslated region (30UTR)
is excised. Excision of the 30UTR did not result in the anticipated mRNA destabilisation and
concomitant knockdown of protein levels. However, the created line proved useful for PDEβ
localisation and enzymatic activity studies. Black arrows denote promoters and lollipops repre-
sent transcription terminators (grey circle represents the heterologous P. berghei dhfr-ts termi-
nator). Positions of PCR amplicons verifying integration as well as absence of wild-type locus
(see [B]) are indicated by black bars. (B) Diagnostic PCRs showing correct integration (INT)
of the plasmid via single crossover into the PDEβ locus as well as absence of wild-type locus
(WT) for two clones. The band obtained with primers specific for the plasmid (PLS) shows
that multiple plasmid copies are integrated into the target locus. (C) Representative images of
formaldehyde-fixed thin smears of ring, trophozoite, and schizont stages of PDEβ-HA para-
sites probed with rat anti-HA monoclonal antibody (green). Parasite nuclei are stained with
DAPI (blue). (D) Full-length PfPDEβ-HA is expressed in early and late ring stages. Total
lysates obtained from synchronous, high parasitaemia ring stage cultures were subjected to
western blot analysis with monoclonal antibodies to the HA tag and the PfGAPDH. A section
of the gel stained for total protein (stain-free gel) is shown as a loading control. (E) Dual-stain-
ing IFAs performed on thin smears of unblocked PfPDEβ-HA schizont cultures. Slides were
stained with anti-HA (red), EBA175, or AMA1 (green). Nuclear material was visualised by
DAPI (blue). Merged red and green channels are shown (merge) and a DIC microscopy image
is shown to the right. Scale bar, 5 μm. AMA1, apical membrane antigen-1; DIC, differential
interference contrast; EBA175, erythrocyte-binding antigen 175; HA, haemagglutinin; hpi,
hours post-invasion; IFA, immunofluorescence assay; INT, integration; PDEβ, phosphodies-
terase β; PfGAPDH, Plasmodium falciparum glyceraldehyde 3-phosphate dehydrogenase;
PfPDEβ, Plasmodium falciparum phosphodiesterase β; PLS, plasmid-specific primer; WT,
wild-type; 3×HA, triple haemagglutinin.
(TIF)
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S3 Fig. Analysis of clones obtained from a RAP-treated PfPDEβΔcatHA culture confirms
essentiality of PDEβ for blood stage growth. (A) PCR analysis of the PDEβ locus in six clones
grown from a RAP-treated culture grown in the absence of WR99210 for 4 weeks. None of the
six clones carried the excised PDEβ locus. A weak or absent integration-specific band is consis-
tent with partial or full reversion of the unexcised PDEβ locus to wild type. (B) Growth curves
for the six clones determined after 4 weeks of culture in the absence of WR99210 by daily
measurements of DNA content via SYBR Green fluorescence (RFU). Means of technical tripli-
cates are presented. Parasite clones were grown in the absence (−WR) and presence (+WR) of
WR99210. Drug challenge reveals that three out of six clones had largely reverted to the drug-
sensitive wild-type PDEβ locus. PDEβ, phosphodiesterase β; PfPDEβ, Plasmodium falciparum
phosphodiesterase β; RAP, rapamycin; RFU, relative fluorescence unit; WR, WR99210.
(TIF)
S4 Fig. Comparison of egress, invasion, and PKG-dependent calcium release in PDEβ KO
and wild-type parasites. (A) Decline in schizontaemia over time in synchronous DMSO- and
RAP-treated PfPDEβΔcatHA schizont cultures as determined by FACS on SYBR Green–
stained cultures. Samples were taken every 45 minutes (T1–T10) and 12 hours later (T11). The
data are mean schizontaemia (starting schizontaemia adjusted to 5%) from two biological rep-
licates carried out in triplicate, and the error bars denote the standard deviation. (B) Increase
in ring stage parasitaemia over time in synchronous DMSO- and RAP-treated PfPDEβΔcatHA
cultures as determined by FACS on SYBR Green–stained cultures. Samples were taken every
45 minutes (T1–T10) and 12 hours later (T11). The data are mean ring stage parasitaemia
(untreated starting parasitaemia adjusted to 1%) from two biological replicates carried out in
triplicate, and the error bars denote the standard deviation. (C) DMSO- and +RAP–treated
PfPDEβΔcatHA schizonts loaded with the membrane-permeable fluorescent calcium reporter
Fluo-4 AM were exposed to PDE inhibitors BIPPO (2 μM) and zaprinast (ZAP) (100 μM),
with or without the PKG inhibitor Compound 2 (C2) (2 μM), and calcium release measured as
Fluo-4 fluorescence. Inhibitor-induced calcium release was normalised to values obtained for
calcium ionophore, which was set to 100%. Data presented are means from three independent
experiments performed in technical triplicates. Error bars, SEM. A paired t test showed no sig-
nificant difference in response to either PDE inhibitor between wild-type (DMSO) and PDEβ
KO schizonts. (D) IFA analysis suggests that mononucleated PDEβ knockout parasites are
inside erythrocytes. Blood films of RAP- and mock-treated PfPDEβΔcatHA cultures contain-
ing segmented schizonts and early ring stages were stained with monoclonal antibodies
recognising MSP1-83, which is shed at invasion, and MSP1-19, which is carried into the eryth-
rocyte. There was no difference between the two conditions in the proportion of parasites
staining with either antibody. Nonsignificant unpaired t test p-values are as follows: MSP1-83,
0.1368; MSP1-19, 0.5442. BIPPO, 5-Benzyl-3-isopropyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-
one; C2, Compound 2; FACS, fluorescence-activated cell sorting; IFA, immunofluorescence
assay; KO, knockout; MSP, merozoite surface protein; PDE, phosphodiesterase; PDEβ, phos-
phodiesterase β; PfPDEβ, Plasmodium falciparum phosphodiesterase β; PKG, cGMP-depen-
dent protein kinase; RAP, rapamycin; ZAP, zaprinast.
(TIF)
S5 Fig. Differential phosphorylation between PDEβ knockout and wild-type schizonts at
phosphosites carrying PKA and control motifs. Intensity plots visualising log2 fold changes
in phosphorylation at individual PKA and control motifs (in red) between PDEβ KO (+RAP)
and wild-type (DMSO) schizonts. The total of 5,374 phosphosites are shown in grey. CRK4
motifs as identified by Ganter and colleagues, 2017 [56], and CDPK1 motifs as identified by
Kumar and colleagues, 2017 [55], were unchanged. Motifs are shown above graphs. n = total
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number of phosphosites identified with a particular motif. Numbers in parentheses denote the
ratio of phosphosites with a particular motif that were found to be significantly increased
(Welch t test) in the PDEβ KO sample. CDPK1, calcium-dependent protein kinase 1; CRK4,
cdc2-related protein kinase 4; KO, knockout; PDEβ, phosphodiesterase β; PKA, cAMP-depen-
dent protein kinase; RAP, rapamycin.
(TIF)
S6 Fig. The PKA inhibitor H89 promotes survival of BIPPO-treated but not cycle 1
PfPDEβ-null ring stages. (A) Representative Giemsa images of RAP- and mock-treated
PfPDEβΔcatHA during cycle 1 post-excision show condensed forms appearing within a few
hours after invasion. (B) RAP- and mock-treated PfPDEβΔcatHA were synchronised to a
2-hour invasion window and inhibitors added to the indicated concentrations at 0 to 2 hours
post-invasion. Blood smears were taken at 20 to 22 hpi, stained with Giemsa, and imaged. (C)
Giemsa-stained smears from ring stage cultures (18–22 hpi) treated with the indicated com-
pounds. Kinase inhibitors (H89 and C2) were added at 1–5 hpi and BIPPO at 2–6 hpi. BIPPO,
5-Benzyl-3-isopropyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one; C2, Compound 2; hpi, hours
post-invasion; PfPDEβ, Plasmodium falciparum phosphodiesterase β; PKA, cAMP-dependent
protein kinase; RAP, rapamycin.
(TIF)
S1 Video. (Related to Fig 4). Time-lapse video of egress in a mock-treated PfPDEβΔcatHA
schizont. PfPDEβ, Plasmodium falciparum phosphodiesterase β.
(MOV)
S2 Video. (Related to Fig 4). Time-lapse video of egress in a RAP-treated PfPDEβΔcatHA
schizont. PfPDEβ, Plasmodium falciparum phosphodiesterase β; RAP, rapamycin.
(MOV)
S3 Video. (Related to Fig 4). Time-lapse video of invasion in mock-treated PfPDEβΔcatHA
merozoites (replicate 1). PfPDEβ, Plasmodium falciparum phosphodiesterase β.
(MOV)
S4 Video. (Related to Fig 4). Time-lapse video of invasion in mock-treated PfPDEβΔcatHA
merozoites (replicate 2). PfPDEβ, Plasmodium falciparum phosphodiesterase β.
(MOV)
S5 Video. (Related to Fig 4). Time-lapse video of invasion in RAP-treated PfPDEβΔcatHA
merozoites showing deformation of erythrocyte. PfPDEβ, Plasmodium falciparum phosphodi-
esterase β; RAP, rapamycin.
(MOV)
S6 Video. (Related to Fig 4). Time-lapse video of invasion in RAP-treated PfPDEβΔcatHA
merozoites showing deformation of erythrocyte and echinocytosis. PfPDEβ, Plasmodium fal-
ciparum phosphodiesterase β; RAP, rapamycin.
(MOV)
S7 Video. (Related to Fig 4). Time-lapse video of invasion in RAP-treated PfPDEβΔcatHA
merozoites showing deformation of erythrocyte, echinocytosis, and invasion. PfPDEβ, Plasmo-
dium falciparum phosphodiesterase β; RAP, rapamycin.
(MOV)
S1 Table. (Related to Fig 5). Quantitative mass spectrometric global phosphoproteome analy-
sis data. Proteins with phosphosites up-regulated 2-fold are highlighted in darker green and
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those significantly up-regulated (Welch t test) in lighter green. Proteins with phosphosites
down-regulated 2-fold are highlighted in darker pink and those significantly down-regulated
(Welch t test) in lighter pink.
(XLSX)
S2 Table. (Related to Fig 5). Protein levels as calculated from the quantification of unpho-
sphorylated peptides present in the phosphopeptide-enriched sample. The two RAP-binding
proteins fused to the two halves of the split Cre recombinase up-regulated >2-fold are
highlighted in green. Significantly down-regulated proteins are highlighted in pink. RAP, rapa-
mycin.
(XLSX)
S3 Table. (Related to Fig 5). Rank-based (1D) annotation motif analysis revealing that PKA-
like substrate motifs are the most highly enriched motifs found in phosphosites up-regulated
in RAP-treated, compared with mock-treated, PfPDEβΔcatHA schizonts. Numbers of detected
phosphosites for each motif are shown in the column ‘Size’, along with test score, p-values, and
mean log2 fold changes. PfPDEβ, Plasmodium falciparum phosphodiesterase β; PKA, cAMP-
dependent protein kinase; RAP, rapamycin.
(XLSX)
S4 Table. (Related to Fig 5). Data underlying the GO analysis presented in Fig 5E. Proteins
that make up the GO terms presented in the bar chart and individual phosphosites in these
proteins are listed in sheet 1. Phosphosites displaying a PKA consensus motif are underlined.
The individual numerical values underlying the bar chart are listed in sheet 2. GO, gene ontol-
ogy; PKA, cAMP-dependent protein kinase.
(XLSX)
S1 Data. Excel file containing the underlying numerical data for Fig 1D.
(XLSX)
S2 Data. Excel file containing the underlying numerical data for Fig 2E.
(XLSX)
S3 Data. Excel spreadsheet containing, in separate sheets, the underlying numerical data
for Fig 3C and 3E.
(XLSX)
S4 Data. Excel spreadsheet containing, in separate sheets, the underlying numerical data
for Fig 4A, 4B, 4C, 4D, 4E and 4E.
(XLSX)
S5 Data. Excel spreadsheet containing, in separate sheets, the underlying numerical data
for Fig 5D and 5E.
(XLSX)
S6 Data. Excel spreadsheet containing, in separate sheets, the underlying numerical data
for Fig 6E and 6G.
(XLSX)
S7 Data. Excel spreadsheet containing the underlying numerical data for Fig 7B.
(XLSX)
S8 Data. Excel spreadsheet containing the underlying numerical data for S3B Fig.
(XLSX)
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S9 Data. Excel spreadsheet containing, in separate sheets, the underlying numerical data
for S4A, S4B, S4C and S4D Fig.
(XLSX)
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